Role of Hyperoxaluria/Hypercalciuria in Controlling the Hydrate Phase Selection of Pathological Calcium Oxalate Mineralization

Jing Zhang,Lijun Wang,Wenjun Zhang,Christine Putnis
DOI: https://doi.org/10.1021/acs.cgd.0c01512
IF: 4.01
2020-01-01
Crystal Growth & Design
Abstract:Both clinical observations and in vitro studies have confirmed that hyperoxaluria or hypercalciuria is one of the main factors that determine the phase formation of pathological calcium oxalate (CaOx) stones, including the monohydrate (COM) at a low Ca/Ox molar ratio and a dihydrate (COD) at a high Ca/Ox molar ratio. However, in situ nanoscale crystallization kinetics and molecular mechanisms remain unclear. Here we show, by time-resolved imaging and phase detection using atomic force microscopy (AFM) and high-resolution transmission electron microscopy (HRTEM), two amorphous calcium oxalate (ACO) phases that are completely different in size can be formed in solutions with different Ca/Ox molar ratios and subsequently aggregate and crystallize into two different hydrate phases via their own different nonclassical pathways. Raman spectroscopy and X-ray photoelectron spectroscopy (XPS) analyses demonstrate that the water content in the two amorphous precursor phases are consistent with that in their corresponding crystalline phases. Moreover, we also observe that COD, as a metastable phase, can spontaneously transform to COM in solutions with a high Ca/Ox molar ratio. Our findings provide direct evidence for Ca to Ox molar ratios in controlling phase selections and crystallization pathways during pathological CaOx stone formation.
What problem does this paper attempt to address?